- Pete Hegseth announced a screening program for troops aged 30 and older to check “right testosterone levels,” calling it the “High-T Department of War.”
- The government will offer opt-in testosterone replacement therapy, which the author notes could be considered gender-affirming care.
- The testosterone announcement is seen as particularly ludicrous given the escalating war with Iran happening simultaneously.
- The Trump administration previously opposed spending on hormones for troops, but now funds testosterone, highlighting a double standard given the defense department spends more on Viagra than transgender healthcare.
Pete Hegseth has announced a controversial initiative mandating testosterone screenings for all U.S. troops over 30, including women, claiming it is vital for military effectiveness. The program, which offers optional testosterone replacement therapy, has drawn criticism for its potential health risks and implications for gender-affirming care.34
Hegseth stated, "By addressing these health markers early, we’re keeping you on the leading edge of lethality." However, endocrinologists warn that unnecessary testosterone supplementation could lead to permanent hormonal issues, ironically undermining the very masculinity the initiative seeks to promote.
The announcement comes amid ongoing scrutiny of Hegseth's leadership as Secretary of Defense, where he has reportedly blocked promotions for women and non-white officers, contributing to significant shortages in senior military ranks. The New York Times noted that this year, no female active-duty naval officers are expected to be promoted to admiral for the first time in over a decade.
Critics argue that Hegseth's focus on testosterone screenings distracts from pressing military issues, especially given the escalating tensions with Iran. The financial implications of this new policy remain unclear, but it has been noted that the defense department spends more on erectile dysfunction medications than on healthcare for transgender troops.
As the military grapples with these changes, the intersection of health, gender identity, and military readiness continues to spark debate.
“Endocrinologists caution that taking unnecessary testosterone supplements can cause permanent inability to produce natural testosterone, ironically emasculating users. The opt-in therapy is also considered a form of gender-affirming care, a shift from the Trump administration's previous reluctance to fund hormones for troops.”
The Guardian
